Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Trimi Health vs Belle Health

Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Belle Health a 85. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Trimi Health

#3 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Trimi Health review →
VS

Belle Health

#32 · Grade A- · Great Deal

Est. first month

$119/mo

Save ~91% vs brand-name
Get this deal Full Belle Health review →

The verdict

Better value: Trimi Health

Trimi Health takes it on Value Score, 89 to 85 an est. $99/mo first month, with no teaser step-up baked in. Belle Health isn't out of it: Shoppers who want flat-rate compounded GLP-1 with free weekly dietitian sessions.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealTrimi HealthBelle Health
Value Score89 (A)85 (A-)
Est. first month$99/mo$119/mo
Save vs brand-name~93%~91%
Semaglutide$99/mo$119/mo
Tirzepatide$125/moFrom $199/mo (all doses, 3-month plan, compounded)
Both moleculesYesYes
PricingFlat — no step-upFlat — no step-up
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
94
Trimi Health: 95. Belle Health: 94.
84
No Teaser-Rate Bait
90
Trimi Health: 84. Belle Health: 90.
98
Nationwide Availability
96
Trimi Health: 98. Belle Health: 96.
94
Both Molecules
92
Trimi Health: 94. Belle Health: 92.
82
Easy Cancellation
58
Trimi Health: 82. Belle Health: 58.
70
Reputation
46
Trimi Health: 70. Belle Health: 46.

Trimi Health

The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.

Why it's a deal

  • Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
  • Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
  • Nationwide 50-state reach, so the low price isn't gated to a handful of states

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
  • Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
  • Newer brand with a thin public track record

Belle Health

Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

Why it's a deal

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

The fine print

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Get the Trimi Health deal Get the Belle Health deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Trimi Health is ranked on the Trimi Health alternatives board, and the same list for the other side is on alternatives to Belle Health.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.